Mathis Grossmann Selected Research

Insulin Resistance

12/2022	Obesity, type 2 diabetes, and testosterone in ageing men.
4/2022	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations.
1/2021	Zoledronic acid does not affect insulin resistance in men receiving androgen deprivation therapy: a prespecified secondary analysis of a randomised controlled trial.
1/2019	Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease.
7/2018	Persisting adverse body composition changes 2 years after cessation of androgen deprivation therapy for localised prostate cancer.
7/2017	Hypothalamic-Pituitary-Thyroid Axis Set Point Alterations Are Associated With Body Composition in Androgen-Deprived Men.
9/2016	Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer.
1/2016	Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus.
9/2015	Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials.
2/2015	Testosterone in men with advanced liver disease: abnormalities and implications.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mathis Grossmann Research Topics

Disease

34	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 03/2011
27	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2024 - 06/2010
22	Type 2 Diabetes Mellitus (MODY) 02/2024 - 05/2008
17	Insulin Resistance 12/2022 - 05/2008
15	Weight Loss (Weight Reduction) 02/2024 - 06/2010
12	Obesity 10/2023 - 06/2010
9	Breast Neoplasms (Breast Cancer) 01/2024 - 11/2016
8	Liver Diseases (Liver Disease) 01/2019 - 08/2012
7	Fibrosis (Cirrhosis) 07/2023 - 02/2015
6	Glucose Intolerance 08/2023 - 01/2019
6	Body Weight (Weight, Body) 01/2021 - 08/2012
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2016 - 06/2010
5	Sarcopenia 01/2023 - 10/2014
5	Overweight 01/2021 - 08/2011
4	End Stage Liver Disease 11/2016 - 08/2012
3	Erectile Dysfunction 10/2023 - 10/2014
3	Non-alcoholic Fatty Liver Disease 07/2023 - 01/2019
3	Neoplasms (Cancer) 01/2023 - 09/2016
3	Inflammation (Inflammations) 12/2022 - 04/2009
3	Hypothyroidism 03/2019 - 10/2008
3	Testicular Diseases 01/2019 - 08/2016
3	Frailty 11/2018 - 09/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2013
3	Chronic Disease (Chronic Diseases) 01/2018 - 08/2011
2	Sleep Apnea Syndromes (Sleep Apnea) 08/2023 - 03/2014
2	Polycythemia (Erythrocytosis) 01/2023 - 01/2022
2	Hyponatremia 01/2023 - 12/2009
2	Wounds and Injuries (Trauma) 12/2021 - 03/2011
2	Primary Hyperparathyroidism 12/2021 - 12/2021
2	Carcinogenesis 01/2019 - 10/2012
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2015
2	Chronic Renal Insufficiency 05/2015 - 04/2009
1	Gliosis 12/2022
1	Confusion (Bewilderment) 04/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Testicular Neoplasms (Testicular Cancer) 01/2022
1	Nephrocalcinosis 12/2021
1	Calculi (Calculus) 12/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2021
1	Vitamin D Deficiency 01/2020
1	Hypocalcemia 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020

Drug/Important Bio-Agent (IBA)

61	Testosterone (Sustanon)FDA Link 02/2024 - 05/2008
42	AndrogensIBA 08/2023 - 03/2011
10	Estradiol (Delestrogen)FDA LinkGeneric 01/2024 - 11/2016
10	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 08/2011
7	SteroidsIBA 10/2020 - 08/2013
6	Hormones (Hormone)IBA 01/2022 - 03/2016
6	Sex Hormone-Binding GlobulinIBA 01/2019 - 06/2010
5	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 08/2013
5	Insulin (Novolin)FDA Link 01/2019 - 06/2010
4	testosterone undecanoateIBA 08/2023 - 11/2016
4	SodiumIBA 04/2022 - 12/2009
3	Denosumab FDA Link 01/2024 - 01/2019
3	Aromatase (CYP19)IBA 01/2024 - 10/2017
3	Aromatase InhibitorsIBA 01/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
3	MineralsIBA 12/2021 - 01/2018
3	Estrogen ReceptorsIBA 07/2019 - 10/2017
3	Thyroxine (Levothyroxine)FDA LinkGeneric 03/2019 - 08/2012
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 03/2019 - 08/2012
3	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2016 - 01/2015
3	Hemoglobins (Hemoglobin)IBA 01/2016 - 10/2014
2	Vasopressins (Vasopressin)IBA 01/2023 - 12/2009
2	LeptinIBA 12/2022 - 04/2017
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 04/2022 - 03/2018
2	CalciumIBA 12/2021 - 01/2020
2	Zoledronic Acid (Zometa)FDA Link 01/2021 - 10/2020
2	Vitamin D FDA LinkGeneric 01/2020 - 05/2013
2	Diphosphonates (Bisphosphonates)IBA 01/2019 - 01/2015
2	Indapamide FDA LinkGeneric 01/2018 - 12/2009
2	ThiazidesIBA 01/2018 - 12/2009
2	Iodide Peroxidase (Deiodinase)IBA 05/2013 - 08/2012
2	AntibodiesIBA 05/2013 - 12/2009
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2023
1	leflutrozoleIBA 01/2023
1	Arginine Vasopressin (Argipressin)IBA 01/2023
1	ElectrolytesIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 12/2022
1	GhrelinIBA 11/2021
1	CytokinesIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	OsteocalcinIBA 01/2021
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	Progesterone FDA LinkGeneric 01/2020
1	CreatinineIBA 01/2020
1	Estrogens (Estrogen)FDA Link 07/2019
1	Lipoprotein(a)IBA 07/2019
1	Tamoxifen FDA LinkGeneric 07/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 07/2019
1	Triglycerides (Triacylglycerol)IBA 07/2019
1	LDL CholesterolIBA 07/2019

Therapy/Procedure

54	Therapeutics 02/2024 - 06/2010
4	Radiotherapy 01/2021 - 09/2016
2	Liver Transplantation 11/2016 - 08/2012
1	Injections 08/2023
1	Resistance Training 01/2023
1	Length of Stay 04/2022
1	Intramuscular Injections 01/2021